Scientific Committee
Biography
Sylvain Chemtob (Canada Research Chair and Leopoldine Wolfe Chair in Vision) is a world-renowned neonatal pharmacologist, and leading authority on mechanisms of retinopathy of prematurity; he pioneered unprecedented biological concepts and contributed to reform care of premature children. His work on ibuprofen to treat the ductus arteriosus is now standard of care. His discovery of novel allosteric anti-inflammatory drugs transforms treatment against preterm birth to improve newborn outcome.
Abstract
Updated Soon...!!
